Outlook on the Topical Corticosteroids Market: Major Segments, Strategic Developments, and Leading Companies

Understanding the prospective growth of the topical corticosteroids market provides valuable insight into how this sector is evolving. Driven by advances in formulation and changing consumer preferences, the market is set to expand notably by 2030. Let's explore the market's size projections, key players, emerging trends, and segment details shaping the future landscape.

Projected Growth and Expansion of the Topical Corticosteroids Market
The topical corticosteroids market is anticipated to experience significant growth over the coming years, reaching a valuation of $13.13 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 7.4%. Several factors will fuel this rise, including the development of novel formulations with fewer side effects, the increasing popularity of over-the-counter hydrocortisone products, wider adoption of online pharmacy channels, growing demand for personalized dermatological treatments, and the rise of home-based skin care solutions. Key trends that are expected to influence the market include the increasing incidence of chronic skin conditions, greater reliance on OTC corticosteroids, broader use of combination topical therapies, growth in both online and retail pharmacy distribution, and a focus on safer, low-potency products suitable for long-term use.

Download a free sample of the topical corticosteroids market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25925&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Companies Driving the Topical Corticosteroids Market
The competitive landscape of the topical corticosteroids market includes prominent industry players such as Merck & Co. Inc., GSK plc, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Menarini Group, Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Lupin Limited, LEO Pharma A/S, Taro Pharmaceutical Industries Ltd., Ajanta Pharma Ltd., Micro Labs Ltd., FDC Limited, Harrow Inc., Salve Pharmaceuticals Pvt. Ltd., Lincoln Pharmaceuticals Ltd., and Emcure Pharmaceuticals Ltd.

Recent Strategic Acquisition in the Topical Corticosteroids Industry
In June 2025, Harrow, a US-based company specializing in ophthalmic pharmaceuticals, acquired exclusive commercial rights in the United States for BYQLOVI (clobetasol propionate ophthalmic suspension) 0.05% from Taiwan's Formosa Pharmaceuticals. While Formosa will continue its independent operations, Harrow will handle the marketing and distribution of this topical corticosteroid in the U.S., ensuring steady availability and brand continuity. Formosa Pharmaceuticals is recognized for its innovation in ophthalmic corticosteroids and oncology drug development, making this partnership a notable strategic move in the market.

View the full topical corticosteroids market report:
https://www.thebusinessresearchcompany.com/report/topical-corticosteroids-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Emerging Trends and Innovations in the Topical Corticosteroids Market
Topical corticosteroid manufacturers are increasingly investing in nanoparticle-based formulations to offer safer and more effective post-surgical anti-inflammatory treatments. This advanced drug delivery system involves encapsulating corticosteroids within nanoparticles, enhancing skin penetration, enabling controlled release, and minimizing systemic side effects. A prime example of this innovation took place in September 2024, when Eyenovia, a U.S. ophthalmic pharmaceutical firm, introduced a clobetasol propionate ophthalmic suspension 0.05%. The formulation utilizes Formosa Pharmaceuticals' APNT nanoparticle technology, delivering a stable nanosuspension that remains evenly mixed throughout the bottle. Patients benefit from twice-daily dosing and fast relief from pain and inflammation after eye surgery, with clinical trials showing nearly 80% of patients experiencing complete pain resolution by day four. This product marks the first new ophthalmic steroid to enter the U.S. market in over 15 years, representing a significant advancement in treatment quality and patient outcomes.

Breakdown of Market Segments in Topical Corticosteroids
This report categorizes the topical corticosteroids market across several key segments:
1) By Type: Prescription and Over-The-Counter (OTC)
2) By Medication Type: Ointments, Creams, Liquids and Solutions, Lotions, Gels, Oils, Pastes, Sprays, and other forms
3) By Distribution Channel: Hospital Pharmacies, Pharmacy Stores, Online Pharmacies, and other channels
4) By Application: Acne, Dermatitis, Psoriasis, Skin Infections, Hyperpigmentation, Melasma, and other uses
5) By End User: Hospitals, Dermatology Clinics, Homecare settings, and other users

Further subsegments include:
- Prescription corticosteroids divided into Potent, Moderate Potency, Mild Topical Corticosteroids, and Prescription Combination Products
- OTC corticosteroids including Hydrocortisone Creams and Ointments, OTC Combination Creams, Corticosteroid Sprays, and Corticosteroid Lotions and Gels

This thorough segmentation helps stakeholders understand market dynamics across different treatment types, distribution methods, and patient needs.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.